key: cord-0847717-iamh9dfn authors: NGANGUE, P.; Pilabre, A. H.; Barro, A.; Pafadnam, Y.; Bationo, N.; Soubeiga, D. title: Public attitudes towards COVID-19 vaccines in Africa: a systematic review date: 2022-04-21 journal: nan DOI: 10.1101/2022.04.19.22274053 sha: 1a307fef6178b1eba7b1786ebc6748cb98031c83 doc_id: 847717 cord_uid: iamh9dfn Background As COVID-19 vaccine acquisition and deployment accelerates, tensions also increase. This review aims to identify and understand the significance of population attitudes toward COVID-19 vaccines in Africa. Methods A systematic review was conducted. Searches were conducted in MEDLINE, CINAHL, EMBASE, and Global Health databases. Database searches began on June 23, 2021, and the last search date was June 30, 2021. The methodological quality of the studies included in this review was assessed using the Mixed methods appraisal tool. Results A total of 609 articles were retrieved, and 23 met the eligibility criteria. All 23 included studies were cross-sectional. Three attitudes were identified: acceptance, reluctance, and refusal to be vaccinated. Acceptance of vaccination was motivated by confidence in the accuracy of the government’s response to COVID-19 and the fact that relatives had been diagnosed with or died from COVID-19. Reluctance was based on fear of vaccine quality and side effects, and insufficient clinical trials. Finally, refusal to be vaccinated was justified by reasons such as the unreliability of clinical trials and insufficient data regarding the vaccine’s adverse effects. Conclusion This review revealed common attitudes of African populations toward COVID-19 vaccines. The results indicate that research needs to focus more on identifying facilitators of COVID-19 vaccination. However, they also provide essential elements for health personnel in charge of vaccination to develop strategies to achieve satisfactory coverage rates 3) (MH "Attitude") OR (MH "Trust") OR (MH "Psychological Distress") OR (TI "Vaccine hesitancy") OR (AB "Vaccine hesitancy") OR (MH "Acceptance and Commitment Therapy") (TI "Conspiracy beliefs") OR (AB "Conspiracy beliefs") OR (MH "intention") OR (MH "motivation") OR (TI "willingness") OR (AB "willingness") OR (MH "fear") OR MH "refusal to participate") Global health 1) "Women" OR "Men" OR "Adult" OR "Health Personnel" OR "Students, Medical" OR "Young Adult" 2) "COVID-19 Vaccines" OR "SARS-CoV-2" 3) "Attitude" OR "Trust" OR "hesitancy" OR "acceptance" OR "refusal" OR "willingness" OR "beliefs " OR "Fear" OR "motivation" OR "intention" All study alerts published in English or French before June 30, 2021, were included. • Selection process A citation management system (Zotero) was used to manage records exported from all electronic databases. Two independent reviewers performed article selection. A predefined selection form was developed to ensure the reliability of article selection by the two reviewers, and a pilot test was conducted based on the eligibility criteria. Both reviewers described the outcome measures after reviewing the studies to verify the relevance of the articles. Each reviewer provided strong justifications for excluding studies. A third reviewer resolved any disagreement between the two reviewers in a consensus meeting. The third reviewer was consulted to decide whether the study met the eligibility criteria for inclusion. Titles and abstracts were used to screen out all studies first, followed by full text to screen out studies that did not meet the inclusion criteria. Database searches initially All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.19.22274053 doi: medRxiv preprint identified a total of 69 studies. After deduplication, 59 potentially relevant titles were included for title or abstract screening. After title and abstract screening, 27 articles were excluded. Finally, the full texts of the remaining 32 studies were reviewed to determine whether they met the inclusion criteria. Ultimately, 23 studies were selected and used for this review. The Preferred Reporting Items for Systematic Reviews and Metanalyses (PRISMA) diagram was used to report the study selection process (Fig. 1) . The two independent reviewers completed a customized data extraction sheet for all included studies. The data extraction tables from both reviewers were matched to ensure that all key outcomes were included in the systematic review. The third reviewer was involved if conflicting information was observed during the data extraction process. We extracted data on the first author, study area, year of study publication, the study scope, estimate, participants, author, rate of acceptance, reasons of acceptance/intention to accept. Some of these extracted data have been presented in tabular form in the "Results" section. The methodological quality of the studies included in this review was assessed using the MMAT (Mixed methods appraisal tool). The MMAT is a critical appraisal tool designed for mixed systematic reviews, including qualitative, quantitative, and mixed methods studies. It assesses the methodological quality of five categories of studies: qualitative research, randomized trials, quantitative descriptive studies, and mixed methods studies [16] . The MMAT Criteria List includes two triage questions and five questions per study category. In addition, the document includes indicators that explain and illustrate certain criteria. For each question, the authors answered by checking "Yes", "I don't know" or "No". One author reviewed six articles, and another reviewed two articles. The authors discussed the evaluation results for all included articles with particular attention to the questions that were checked "don't know" or "no". The main findings of the studies were analyzed and summarized narratively. In addition, a systematic narrative synthesis was provided with the information presented in the text All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The results of the review were synthesized narratively. First, we performed a descriptive analysis of all included final studies to record their main characteristics. A narrative synthesis was then performed in which the final studies were grouped according to key attitudes. A total of 61 articles were retrieved through various searches. After removing duplicates, there were 51 articles, and 23 met the inclusion and exclusion criteria. All 23 included studies were cross-sectional studies. The studies were carried out in Ethiopia (n = 6), Uganda (n = 3), Egypt (n = 4), Nigeria (= 2), Ghana (n = 2), Democratic Republic of the Congo (n = 1), South Africa (n=2), Tunisia (n=1) and in Libya (n = 1). Study populations were diverse including general population (n = 8), adults aged 18 to 70 (n = 1), healthcare workers (n = 9), medical students (n = 2), pregnant women attending an antenatal care clinic (n = 1), patients attending outpatient clinics (n = 1), and elementary and secondary school teachers (n = 1) (see tables 1, 2, 3). In terms of methodological quality, twenty studies were of good quality, two of moderate quality and one of poor quality. • Results of individual studies • Results of synthesis All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.19.22274053 doi: medRxiv preprint and others felt that it is the community's responsibility to get vaccinated. [22] Speaking of responsibility, pregnant women must observe good practices about COVID-19 and its preventive measures, including vaccination. [24] Moreover, it appears that the main factor likely to increase acceptance of vaccination is obtaining sufficient and precise information on available vaccines. [22] Rates and reasons for vaccines acceptance are presented in table 1. The rates of hesitancy to be vaccinated against COVID-19 reported by studies vary from around 1,06 to 85%. [17, 28, 20, 22, 25, [30] [31] [32] [35] [36] [37] [38] Study participants who say they are reluctant to get vaccinated against COVID-19 consist of the general population aged 18 and over, [17, 27, 28, 35, 36] adults aged 18 to 70, [20] healthcare workers [22, [29] [30] [31] [32] [33] [34] 37] and medical school students. [25] In addition, people aged 61 to 70, unemployed and pagan participants, the singles group and city dwellers were reluctant to accept the vaccine. [20] Study participants cite several reasons to justify their hesitation. For example, there is the fear of the quality of the vaccine distributed or sent to Africa, [27] the lack of sufficient clinical trials, insufficient information on the possible effects of the vaccine, uncertainty about the quality of the vaccine, uncertainty about the effectiveness of the vaccine in preventing them from contracting COVID-19, [28] the unclear information provided by public health authorities, the low risk of contracting COVID-19 Infection, uncertainty regarding the tolerability of side effects of the vaccine, [30] strong concerns about unintended effects of the vaccine [35] and the fear of side effects of the vaccine. [22] Rates and reasons for hesitancy to get vaccinated are presented in the table 2. The studies included in this review report refusal rates ranging from 6 to approximately 61%. [17, 19, 19, 25, 28, 33, 39] Medical students, [25] healthcare workers [22, 28, 32, 33, 39] and adults aged 18 and over [17, 19, 28, 35, 36] were the participants in the studies that reported these refusals. Male participants, singles, and those who perceive a very high or moderate risk of contracting COVID-19 in the future are the most represented among those who refuse to be vaccinated. [29] All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The main reasons cited by those who refused COVID-19 vaccines are multiple. These reasons include the unreliability of clinical trials, the belief that their immune system is sufficient to fight the virus, [14] the lack of confidence in the vaccine and the lack of confidence in pharmaceutical companies to produce a safe and effective vaccine. [17, 22, 25, 34, 38] In addition, many claimed to have learned that all available vaccines for COVID-19 are under the Emergency Use Authorization (EUA) umbrella. [34] Furthermore, concerns about the vaccine's adverse effects and ineffectiveness have led some people to refuse vaccination. [22, 28] In addition to these reasons, there are perceptions that the vaccine was intended to kill people in Africa, sterilize people [19] and doubt that the side effects are openly discussed. [22] Furthermore, the duration of protection and immunity is unknown, and rumors about the vaccine version are available. [22] Globally, the main obstacles to vaccination against COVID-19 are insufficient data regarding the vaccine's adverse effects and insufficient information about the vaccine itself. [25] Rates and reasons for refusal to be vaccinated are presented in table 3. This systematic review aimed to report attitudes and reasons associated with COVID-19 vaccination in Africa regardless of the study participants and design. Three attitudes have been identified: vaccination acceptance, hesitancy, and refusal to be vaccinated. Several reasons have been associated with each attitude. Addressing these attitudes can help improve immunization coverage in Africa. Previous reviews have focused more on acceptance rates (intention), hesitation and refusal. However, they have not studied attitudes in detail to propose effective strategies. Vaccination acceptance motivators were confidence in the government's accuracy of measures to fight COVID-19 and that relatives have been diagnosed or died of COVID- The hesitancy was justified by reasons such as fear of the quality of the vaccine being distributed or sent to Africa, the lack of sufficient clinical trials and fear of the vaccine's side effects. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The refusal to be vaccinated was justified by reasons such as the unreliability of clinical trials, the belief that their immune system is sufficient to fight the virus, insufficient data regarding the vaccine's adverse effects, and insufficient information regarding the vaccine itself. The systematic review found that vaccine acceptance rates or willingness to be vaccinated against COVID-19 ranged from 6 to 92%. [17] [18] [19] [20] [21] [22] [23] [24] [25] 39] Studies of Ebola vaccination have reported results of varying acceptance rates. Huo et al., [40] in their study titled "Knowledge and attitudes about Ebola Vaccine among the General Population in Sierra Leone", reported that 72.5% of participants were willing to be vaccinated against Ebola if it was free. In a national household survey in Guinea, Irwin et al. [41] reported that 84.2% of participants said their family would accept Ebola vaccines. Always in Guinea, Kpanake et al. [42] found that 38% of participants said they were always ready to be vaccinated. Differences could be explained by study participants and the survey timing (before or during vaccination; before, during or after the epidemic). In this systematic review, the reasons to get vaccinated against COVID-19 are similar to those for vaccination against Ebola. These reasons are mainly: the capacity of vaccination to prevent disease, the severity of the disease (its high case fatality rate), the safety of the vaccine, its efficacy and its availability. [27, 21, 22, 30, 31] Therefore, to convince people to get vaccinated against covid 19, the communication must be focused on the consequences of the disease, vaccine availability, its safety and effectiveness. The rates of reluctance to be vaccinated against COVID-19 reported by studies vary from around 1,6 to 85%. [17, 28, 20, 22, 25, [30] [31] [32] [36] [37] [38] In their study on why the Guinean people were vaccinated against Ebola. Kpanake et al. [42] found a reluctance rate of 19%. This rate is a little low compared to the rates revealed by this systematic review. This could be explained by the nature of the pathologies and the effectiveness of communication actions. The reasons for reluctance to be vaccinated are often fearful of the quality of the vaccine distributed or sent to Africa, [28] lack of sufficient clinical trials and fear of vaccine side effects. [22] The rapidity of vaccine circulation, poor communication, the withdrawal of certain vaccines, the abundance of debates and information could support the hesitation. If actions are not taken to reassure populations about the quality and side effects of All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The results of Huo et al. [40] Ebola vaccination study showed that 42% of participants did not intend to be vaccinated. In their study on the positions of the Guinean people to be vaccinated against Ebola, Kpanake et al. [32] reported that 25% of participants said they never wanted to be vaccinated. The results of these two studies range from 6 to about 61% [17, 19, 22, 25, 28, 34, 38] revealed by this systematic review. This difference could be explained by the diversity of research methods and the experimental or licensed nature of the vaccines. Concerns about vaccine side effects, vaccine safety and efficacy [19, 22, 25, 30] and the belief of study participants that their immune system is sufficient to fight the virus [20] are the most common reasons for refusing vaccinations. Therefore, it is essential to communicate about disease and vaccine effectiveness to avoid these false beliefs. It is also vital to build and strengthen trust with populations to ensure vaccination acceptance. [28, 31, 32] Unfortunately, this situation could lead to an increase in the rate of refusal to be vaccinated the persistence of the pandemic with a high case fatality rate. The main strengths of this systematic review lie in the fact that it included all studies regardless of the design. In addition, the included studies looked at both the general population and specific groups. In addition, document searches were carried out in several databases and in gray literature to reduce the risks associated with publication bias. There may be selection bias due to the restriction of publication languages. For example, the research looked at articles published in French or English. In addition, the synthesis was not conducted to have visibility of attitudes and reasons by type of participant. Furthermore, this review did not address the association of reasons with sociodemographic variables. Debates have been intense around COVID-19 vaccines since the start of vaccination campaigns. As a result, several studies have been carried out to determine people's attitudes towards these vaccines. This systematic review looked at the attitudes of people All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. in Africa towards COVID-19 vaccines. The included studies had the general population aged 18 and over and specific groups as participants. Three attitudes were reported at different rates; acceptance of vaccination, reluctance and refusal to be vaccinated. The safety, quality, side effects of vaccines and knowledge about COVID-19 are the main factors determining these attitudes. Therefore, this systematic review helps to understand the attitudes of the populations of Africa towards vaccines against COVID-19. Meanwhile, the results indicate that research needs to focus more on identifying the facilitators of COVID-19 vaccination. This is to increase the acceptance rate significantly and, at the same time, reduce the hesitation and refusal rates. This research also provides essential elements for health personnel in charge of vaccination to develop strategies likely to obtain satisfactory coverage rates. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. To protect themselves and their families, they believe in vaccination, they believe that vaccination is compulsory for health workers. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 21, 2022. ; https://doi.org/10.1101/2022.04.19.22274053 doi: medRxiv preprint From SARS to COVID-19 : What we have learned about children infected with COVID-19